Specifically, we propose that CD180 overexpression in macrophages may affect the secretion of immunomodulatory cytokines (e.g., IL-10, TGF-β) that suppress anti-tumor immunity and promote glioma cell proliferation. The gene discussed is TGFB1; the disease is neoplasm.